FDA Recall Terminated

Philips Hemodynamic Application, Model Number 722463, Software Version Number: R1.2.2 and R1.2.3. For visualization and analysis of patient hemodynamic data in the Philips Interventional Hemodynamic System.

Recall: Z-1041-2022 · Initiated February 22, 2022

Recall

Recall Number
Z-1041-2022
Event Number
89878
Firm
Philips North America Llc
FEI Number
3016618143
Product Code
MWI
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
February 22, 2022
Terminated
November 6, 2024
Address
222 Jacobs St, Cambridge, MA, 02141-2289

Description

Philips Hemodynamic Application, Model Number 722463, Software Version Number: R1.2.2 and R1.2.3. For visualization and analysis of patient hemodynamic data in the Philips Interventional Hemodynamic System.

Reason

When a Neonatal patient is admitted, the Non-Invasive Blood Pressure is not set to Neonatal mode on the Philips Xperflex Cardio FC2010 patient monitor. If the NIBP is not set to Neonatal, the cuff inflation pressure applied will be higher than 150 mmHg and the deflation pressure will be higher than 5 mmHg. An applied cuff inflation pressure higher than 150mmHg or a deflation pressure higher than 5 could lead to bruising, mmHg nerve damage or bone deformity for a neonate.

Action

An URGENT Medical Device Correction notification letter dated 2/18/22 was sent to customers. Actions that should be taken by the customer/ user in order to prevent risks for patients. Do not use the Non-Invasive Blood Pressure for Neonatal Patients until Philips has installed a new software revision that will solve this problem. Place this Urgent Medical Device Correction letter with the documentation of the Philips Hemodynamic Application until Philips implements the new software revision. Return the attached reply form to Philips to confirm that the users of the system have reviewed and understood this Urgent Medical Device Correction letter. Actions planned by Philips to correct the problem. To correct this problem, Philips will install a new software revision to update the Hemodynamic Application to revision Rl.3. This new revision will be available as of March 2022. Philips will be contacting customers with an affected Philips Hemodynamic Application to install the new software revision. Please be assured that maintaining a high level of safety and quality is our highest priority. If you need any further information, please contact your local Philips Cardiology representative.

Distribution

Devices were distributed to the following US states: FL, ID, NJ, OK, SC and TX. Devices were distributed to the following foreign countries: France, Germany, India, Mexico, Netherlands, New Zealand, Norway, Poland, South Africa, and Switzerland.

Quantity

77